Chronic atrophic gastritis type C2 belongs to the moderate atrophy and generally has a good prognosis after active treatment in the clinic.
Chronic atrophic gastritis type C2 means that the atrophic limit is just over the gastric angle, located in the lower part of the body of the stomach on the side of the lesser curvature, which belongs to the intermediate-risk group and is generally not serious. The common clinical cause is Helicobacter pylori infection, and a small percentage of causes are due to autoimmune factors. Common clinical symptoms include epigastric pain, fullness, nausea and flatulence.
As a precancerous lesion, atrophic gastritis is a potential factor for the development of gastric cancer. When severe atypical hyperplasia occurs in the gastric mucosa, immediate prophylactic surgery is needed to remove the abnormal gastric mucosa, and attention should be paid to regular review to prevent the disease from progressing.
When patients are diagnosed with chronic atrophic gastritis type C2, they should go to the hospital in time to have their condition evaluated by a professional physician and receive appropriate treatment to avoid delaying their condition.